3′-Azido-3′-deoxythymidine (AZT) is a competitive inhibitor of thymidine phosphorylation in isolated rat heart and liver mitochondria
- 25 April 2006
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 72 (2) , 239-243
- https://doi.org/10.1016/j.bcp.2006.04.004
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Deoxyribonucleotide Pool Imbalance Stimulates Deletions in HeLa Cell Mitochondrial DNAJournal of Biological Chemistry, 2003
- Dilated Cardiomyopathy in an Adult Human Immunodeficiency Virus Type 1-Positive Patient Treated with a Zidovudine-Containing Antiretroviral RegimeClinical Infectious Diseases, 2003
- Zidovudine Phosphorylation and Mitochondrial Toxicity in VitroToxicology and Applied Pharmacology, 2001
- Differential Incorporation and Removal of Antiviral Deoxynucleotides by Human DNA Polymerase γJournal of Biological Chemistry, 2001
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.Journal of Clinical Investigation, 1992
- Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunctionAnnals of Neurology, 1991
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978